Literature DB >> 32307302

The Voyager PAD Trial - New Path for Post-revascularisation PAD Patients.

E Sebastian Debus1, Mark R Nehler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32307302     DOI： 10.1016/j.ejvs.2020.03.041

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN： 1078-5884            Impact factor:   7.069


× No keyword cloud information.
  2 in total

1.  Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation.

Authors:  Antonio Trani; Pietro Benedetto; Ferdinando Di Leo; Angela Baiano; Andrea Esposito; Danilo Menna; Arianna Allegretti; Pierluigi Antonino Cappiello; Domenico Dell'Edera
Journal:  J Pharm Health Care Sci       Date:  2020-08-03

2.  Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials.

Authors:  Tao Tang; Ming Zhang; Wendong Li; Nan Hu; Xiaolong Du; Feng Ran; Xiaoqiang Li
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.